TRACON PHARMACEUTICALS INC (TCON) Stock Cash Flow
NASDAQ:TCON - Nasdaq - US89237H3084 - Common Stock - Currency: USD
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 1.75M | -3.59M | -29.14M | -28.67M | -16.77M | |||
| Depreciation Amortization | 14.00K | 14.00K | 16.00K | 14.00K | 12.00K | |||
| Change In Working Capital | -3.71M | -2.15M | -239.00K | 4.54M | -1.45M | |||
| Interest Paid | N/A | 7.49M | 359.00K | 266.00K | 443.00K | |||
| Other non cash items | 8.09M | 9.40M | 3.12M | 1.54M | 1.17M | |||
| OPERATING CASH FLOW | 6.14M | 3.68M | -26.24M | -22.57M | -17.04M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -17.00K | -48.00K | -5.00K | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | 4.00M | -4.00M | |||
| INVESTING CASH FLOW | N/A | 0.00 | -17.00K | 3.95M | -4.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -10.50M | -20.50M | 8.28M | -2.80M | -1.40M | |||
| Stock Issued/Repurchased | 5.65M | 7.96M | 7.97M | 13.36M | 38.16M | |||
| Other Financing Activity | N/A | N/A | 3.43M | N/A | N/A | |||
| FINANCING CASH FLOW | -4.85M | -12.54M | 19.68M | 10.56M | 36.76M | |||
| CHANGE IN CASH | 1.29M | -8.86M | -6.57M | -8.06M | 15.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6.14M | 3.68M | -26.24M | -22.57M | -17.04M | |||
| Capital Expenditure | N/A | 0.00 | -17.00K | -48.00K | -5.00K | |||
| FREE CASH FLOW | 6.14M | 3.68M | -26.26M | -22.62M | -17.05M | |||
All data in USD